Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03032159 · ClinicalTrials.gov registry record · NA

Text2Breathe: Enhance Parent Communication to Reduce Pediatric Asthma Disparities

A NA study of Asthma, sponsored by Seattle Children's Hospital.

Completed
Registry status
NA
Development phase
221
Enrollment target
2
Study locations

NCT03032159 is a NA study of Asthma that has completed, run by Seattle Children's Hospital. The registered enrollment target is 221 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (86% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03032159, a NA study of Asthma, has completed, sponsored by Seattle Children's Hospital.

COMPLETED
Registry status
NA
Development phase
221 participants
Enrollment target
2
Study locations

Study Summary

Text2Breathe (T2B) is a randomized controlled trial aimed at improving communication between parents and their children's' primary care providers about asthma. The overarching goal of this study is to reduce disparities among a population with high rates of pediatric asthma morbidity. The investigators are testing the efficacy of a short message service (SMS)-enhanced health communication (HC) intervention ("Text2Breathe") designed to equip urban, low-income parents with tools for communicating effectively with their children's primary care provider (PCP).

Conditions Studied

Interventions

  • BEHAVIORAL Text2Breathe Study Group

Study Locations (2)

Washington

  • Seattle Children's - Seattle
  • Mary Bridge Children's Hospital at Multi Care Health System - Tacoma

Trial Details

FieldValue
Enrollment Target 221 participants
Start Date 2015-08
Est. Completion 2020-03
Phase NA

Sponsor

Seattle Children's Hospital

168 total trials

What the Registry Record Tells You About NCT03032159

The ClinicalTrials.gov registry entry for NCT03032159 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 221 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (86% lower). The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Text2Breathe Study Group is the first listed.

NCT03032159 reports 2 study locations spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT03032159 about?

NCT03032159 is a clinical study titled "Text2Breathe: Enhance Parent Communication to Reduce Pediatric Asthma Disparities". Text2Breathe (T2B) is a randomized controlled trial aimed at improving communication between parents and their children's' primary care providers about asthma. The overarching goal of this study is to reduce disparities among a population with high rates of pediatric asthma morbidity. The investigat...

What is the current status of trial NCT03032159?

This trial is currently completed. It is a NA study. The enrollment target is 221 participants. The study started on 2015-08. Estimated completion is 2020-03.

What conditions does trial NCT03032159 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT03032159?

The interventions under investigation include: Text2Breathe Study Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT03032159?

This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03032159 being conducted?

This trial has 2 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.